Research Topics
| Felicity NgSummaryAffiliation: Barwon Health Country: Australia Publications
|
Detail Information
Publications
The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment programKristi Ann Villagonzalo
Department of Clinical and Biomedical Sciences, University of Melbourne, PO Box 281, Geelong, Victoria 3220, Australia
Compr Psychiatry 52:562-6. 2011..This study explores the relationship between substance abuse and PTSD symptom clusters in a methadone maintenance population...
Combination pharmacotherapy in unipolar depressionFelicity Ng
University of Melbourne, Department of Clinical and Biomedical Sciences Barwon Health, PO Box 281, Geelong, Victoria, Australia
Expert Rev Neurother 6:1049-60. 2006..This paper reviews the current evidence for combination pharmacotherapy in unipolar depression and discusses its clinical applications...
The effects of physical activity in the acute treatment of bipolar disorder: a pilot studyFelicity Ng
Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Victoria, Australia
J Affect Disord 101:259-62. 2007..This study is a pilot investigation into the effectiveness of an adjunctive walking program in the acute treatment of bipolar disorder...
The interface between religion and psychosisFelicity Ng
Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Vic, Australia
Australas Psychiatry 15:62-6. 2007..This paper aims to explore the interface between religion and psychosis, and to comment on its relevance in clinical practice...
Oxidative stress in psychiatric disorders: evidence base and therapeutic implicationsFelicity Ng
Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Vic, Australia
Int J Neuropsychopharmacol 11:851-76. 2008..These data not only suggest that oxidative mechanisms may form unifying common pathogenic pathways in psychiatric disorders, but also introduce new targets for the development of therapeutic interventions...
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in maniaMichael Berk
University of Melbourne, Victoria, Australia
J Affect Disord 110:126-34. 2008..This study aimed to compare the treatment responses between smokers and non-smokers in bipolar mania clinical trials...
Glutathione: a novel treatment target in psychiatryMichael Berk
Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Victoria, Australia
Trends Pharmacol Sci 29:346-51. 2008..This article outlines the multidimensional evidence that currently exists for oxidative stress mechanisms in psychiatric disorders and specifically discusses glutathione as a promising novel therapeutic target...
The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical useMichael Berk
Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Victoria, Australia
J Eval Clin Pract 14:979-83. 2008..The Clinical Global Impression Scale (CGI) is established as a core metric in psychiatric research. This study aims to test the validity of CGI as a clinical outcome measure suitable for routine use in a private inpatient setting...
Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sampleMichael Berk
Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Australia
Aust N Z J Psychiatry 42:874-8. 2008..The aim of the present study was to investigate the relationship between reduced serum vitamin D levels and psychiatric illness...
Tobacco smoking as a risk factor for major depressive disorder: population-based studyJulie A Pasco
Department of Clinical and Biomedical Sciences Barwon Health, The University of Melbourne, PO Box 281, Geelong 3220, Australia
Br J Psychiatry 193:322-6. 2008..Smoking is disproportionately prevalent among people with psychiatric illness...
The empirical redefinition of the psychometric criteria for remission in bipolar disorderMichael Berk
Barwon Health and The Geelong Clinic, Geelong, Victoria, Australia
J Affect Disord 106:153-8. 2008....
Effects of a walking program in the psychiatric in-patient treatment setting: a cohort studyFelicity Ng
Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Victoria, Australia
Health Promot J Austr 18:39-42. 2007..To assess the effectiveness of a walking program in a psychiatric in-patient unit...
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophreniaMichael Berk
Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, PO Box 281, Geelong 3220, Victoria, Australia
J Clin Psychiatry 72:909-13. 2011..To our knowledge, this mixed methodology has not previously been applied to blinded psychopharmacologic trials...
Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorderMichael Berk
Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Swanston Centre, VIC 3220, Australia
Psychiatry Clin Neurosci 64:367-71. 2010..This approach has the potential to capture a broader, more fine-grained and clinically relevant picture of the process of aggravation of the bipolar cycle...
Client-reported reasons for non-engagement in drug and alcohol treatmentCarolyn Coulson
Department of Clinical and Biomedical Sciences, Barwon Health, The University of Melbourne, Geelong, Australia
Drug Alcohol Rev 28:372-8. 2009..To examine client-reported reasons for missed early appointments at a drug and alcohol treatment service and to compare characteristics of those who missed appointments with those who attended...
The role of lamotrigine in the management of bipolar disorderFelicity Ng
Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Victoria, Australia
Neuropsychiatr Dis Treat 3:463-74. 2007..Further randomized controlled trials are required to consolidate the available findings and to explore the boundaries of lamotrigine's efficacy, which may encompass the soft spectral disorders...
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depressionGin S Malhi
Discipline of Psychological Medicine, University of Sydney, Sydney, New South Wales, Australia
Aust N Z J Psychiatry 42:346-9. 2008..This paper describes a prospective case series that examined the efficacy of the venlafaxine-mirtazapine combination in the treatment of depressed patients who had failed at least one antidepressant trial...
